(NASDAQ: MRUS) Merus Nv's forecast annual revenue growth rate of 31.15% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 97.96%, and while it is forecast to beat the US market's average forecast revenue growth rate of 25.83%.
Merus Nv's revenue in 2025 is $69,763,000.On average, 22 Wall Street analysts forecast MRUS's revenue for 2025 to be $4,277,406,722, with the lowest MRUS revenue forecast at $3,136,628,409, and the highest MRUS revenue forecast at $6,530,218,252. On average, 22 Wall Street analysts forecast MRUS's revenue for 2026 to be $4,141,341,547, with the lowest MRUS revenue forecast at $1,345,331,142, and the highest MRUS revenue forecast at $10,798,751,158.
In 2027, MRUS is forecast to generate $13,771,858,655 in revenue, with the lowest revenue forecast at $1,822,545,233 and the highest revenue forecast at $47,686,520,600.